...
search icon
tnya-img

Tenaya Therapeutics Inc Share Price

TNYA
NSQ
$0.66
-$0.02
(-2.93%)
1D
Industry: Biotechnology Sector: Health Care

Tenaya Therapeutics Inc Analyst Forecast

Tenaya Therapeutics Inc Share Price Chart

Tenaya Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$148.00M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.45M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
3.19
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.36 L
$2.35 H
$0.66

About Tenaya Therapeutics Inc, Common Stock

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company's lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. The company develops its products through gene editing, cellular regeneration, gene silencing, and gene addition. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Tenaya Therapeutics Inc Stock Returns

Time FrameTNYASectorS&P500
1-Week Return-18.57%-1.08%-1.38%
1-Month Return-12.94%-0.47%-1.81%
3-Month Return-51.77%2.13%1.38%
6-Month Return-23.26%17.04%5.68%
1-Year Return-30.23%6.56%11.74%
3-Year Return-77.9%16.78%65.15%
5-Year Return-95.7%34.34%73.68%

Tenaya Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue2.48M4.03M8.71M8.69M8.47M[{"date":"2020-12-31","value":28.5,"profit":true},{"date":"2021-12-31","value":46.2,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":99.7,"profit":true},{"date":"2024-12-31","value":97.19,"profit":true}]
Gross Profit(2.48M)(4.03M)(8.71M)(8.69M)(8.47M)[{"date":"2020-12-31","value":-248300000,"profit":false},{"date":"2021-12-31","value":-402500000,"profit":false},{"date":"2022-12-31","value":-871300000,"profit":false},{"date":"2023-12-31","value":-868700000,"profit":false},{"date":"2024-12-31","value":-846800000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses36.43M72.81M125.62M122.51M107.48M[{"date":"2020-12-31","value":29,"profit":true},{"date":"2021-12-31","value":57.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":97.52,"profit":true},{"date":"2024-12-31","value":85.56,"profit":true}]
Operating Income(38.91M)(72.81M)(125.62M)(131.19M)(115.95M)[{"date":"2020-12-31","value":-3891200000,"profit":false},{"date":"2021-12-31","value":-7280600000,"profit":false},{"date":"2022-12-31","value":-12562100000,"profit":false},{"date":"2023-12-31","value":-13119300000,"profit":false},{"date":"2024-12-31","value":-11594800000,"profit":false}]
Total Non-Operating Income/Expense604.00K193.00K3.91M13.73M9.56M[{"date":"2020-12-31","value":4.4,"profit":true},{"date":"2021-12-31","value":1.41,"profit":true},{"date":"2022-12-31","value":28.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":69.59,"profit":true}]
Pre-Tax Income(38.40M)(72.72M)(123.67M)(124.08M)(111.13M)[{"date":"2020-12-31","value":-3839500000,"profit":false},{"date":"2021-12-31","value":-7272100000,"profit":false},{"date":"2022-12-31","value":-12366500000,"profit":false},{"date":"2023-12-31","value":-12408400000,"profit":false},{"date":"2024-12-31","value":-11112900000,"profit":false}]
Income Taxes(87.00K)(3.07M)(1.96K)8.52M(111.13M)[{"date":"2020-12-31","value":-1.02,"profit":false},{"date":"2021-12-31","value":-36.02,"profit":false},{"date":"2022-12-31","value":-0.02,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-1304.47,"profit":false}]
Income After Taxes(38.31M)(69.65M)(123.66M)(132.60M)-[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(38.40M)(72.72M)(123.67M)(127.67M)(111.13M)[{"date":"2020-12-31","value":-3839500000,"profit":false},{"date":"2021-12-31","value":-7272100000,"profit":false},{"date":"2022-12-31","value":-12366500000,"profit":false},{"date":"2023-12-31","value":-12766500000,"profit":false},{"date":"2024-12-31","value":-11112900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(38.40M)(69.65M)(123.66M)(124.08M)(111.13M)[{"date":"2020-12-31","value":-3839500000,"profit":false},{"date":"2021-12-31","value":-6965200000,"profit":false},{"date":"2022-12-31","value":-12366304400,"profit":false},{"date":"2023-12-31","value":-12408400000,"profit":false},{"date":"2024-12-31","value":-11112900000,"profit":false}]
EPS (Diluted)(11.93)(14.97)(2.79)(1.67)(1.32)[{"date":"2020-12-31","value":-1193.09,"profit":false},{"date":"2021-12-31","value":-1497,"profit":false},{"date":"2022-12-31","value":-279,"profit":false},{"date":"2023-12-31","value":-167,"profit":false},{"date":"2024-12-31","value":-132,"profit":false}]

Tenaya Therapeutics Inc Ratios

Tenaya Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

TNYA
Cash Ratio 4.26
Current Ratio 4.64

Tenaya Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TNYA
ROA (LTM) -49.48%
ROE (LTM) -96.44%

Tenaya Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TNYA
Debt Ratio Lower is generally better. Negative is bad. 0.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.79

Tenaya Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TNYA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 1.79
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Tenaya Therapeutics Inc share price today?

Tenaya Therapeutics Inc (TNYA) share price today is $0.66

Can Indians buy Tenaya Therapeutics Inc shares?

Yes, Indians can buy shares of Tenaya Therapeutics Inc (TNYA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TNYA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tenaya Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Tenaya Therapeutics Inc (TNYA) via the Vested app. You can start investing in Tenaya Therapeutics Inc (TNYA) with a minimum investment of $1.

How to invest in Tenaya Therapeutics Inc shares from India?

You can invest in shares of Tenaya Therapeutics Inc (TNYA) via Vested in three simple steps:

  • Click on Sign Up or Invest in TNYA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tenaya Therapeutics Inc shares
What is Tenaya Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Tenaya Therapeutics Inc (TNYA) is $2.35. The 52-week low price of Tenaya Therapeutics Inc (TNYA) is $0.36.

What is Tenaya Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tenaya Therapeutics Inc (TNYA) is

What is Tenaya Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tenaya Therapeutics Inc (TNYA) is 1.79

What is Tenaya Therapeutics Inc dividend yield?

The dividend yield of Tenaya Therapeutics Inc (TNYA) is 0.00%

What is the Market Cap of Tenaya Therapeutics Inc?

The market capitalization of Tenaya Therapeutics Inc (TNYA) is $148.00M

What is Tenaya Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Tenaya Therapeutics Inc is TNYA

How Can Investors Use Tenaya Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Tenaya Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Tenaya Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Tenaya Therapeutics Inc shares for Indian investors?

When investing in Tenaya Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Tenaya Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Tenaya Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Tenaya Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Tenaya Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top